Przegląd Dermatologiczny

Abstract

5/2022 vol. 109
Case report

Extramammary Paget disease of the vulva treated with imiquimod

  1. Department of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland; Klinika Dermatologii, Wenerologii i Alergologii, Wydział Lekarski, Gdański Uniwersytet Medyczny, Gdańsk, Polska
  2. Department of Adult Psychiatry, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland; Klinika Psychiatrii Dorosłych, Wydział Lekarski, Gdański Uniwersytet Medyczny, Gdańsk, Polska
Dermatol Rev/Przegl Dermatol 2022, 109, 368-376
Online publish date: 2023/03/16
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction:

Extramammary Paget disease of the vulva is a rare, malignant skin neoplasm that typically develops in postmenopausal Caucasian women.

Case report:

A 70-year-old women reported to the Dermatology Outpatient Clinic with a history of extramammary Paget disease of the vulva, with positive margins after vulvectomy. Considering non-resectability of the lesion, a decision was made to use imiquimod in local therapy on the remaining extramammary Paget disease foci, clinically corresponding to the areas of whitening within the vulva. After 3 months of local therapy, clinical improvement was achieved, and 10 months after the end of treatment, remission was confirmed in histopathological examination based on biopsy.

Conclusions:

Surgical excision of lesions remains the standard procedure in extramammary Paget disease. Subsequent treatment with imiquimod appears to be beneficial in cases of positive excision margins, to avoid further, mutilating surgery.

Share
without publication fees
without publication fees